Clinical Trial · NCT05826158

18F-mFBG LAFOV PET/CT Compared to 123I-mIBG Scintigraphy SPECT/CT for Evaluation of Children With Neuroblastoma

Overview

This is a study evaluating the positron-emitting radiopharmaceutical 18F-mFBG compared to 123I-mIBG scintigraphy for imaging of neuroblastoma

Sponsor

Rigshospitalet

Phase

N/A

Contacts

Lise Borgwardt, MD, PhD. (Principal Investigator)

lise.borgwardt@regionh.dk

+4535459568

ClinicalTrials.gov

NCT05826158